Cargando…
Analytical performance of the BD veritor™ system for rapid detection of influenza virus A and B in a primary healthcare setting
BACKGROUND: Infections with influenza A virus cannot be clinically differentiated from infections caused by influenza B virus or other respiratory viruses. Additionally, although antiviral treatment is available for influenza A virus, it is not effective for the other viruses and must be initiated e...
Autores principales: | Mese, Sevim, Akan, Hulya, Badur, Selim, Uyanik, Aysun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016879/ https://www.ncbi.nlm.nih.gov/pubmed/27612949 http://dx.doi.org/10.1186/s12879-016-1811-9 |
Ejemplares similares
-
Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003–2016 retrospective analysis
por: Meşe, Sevim, et al.
Publicado: (2018) -
Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19
por: Kilic, Abdullah, et al.
Publicado: (2021) -
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System
por: Christensen, Katherine, et al.
Publicado: (2022) -
Application of an immunoglobulin Y-alkaline phosphatase bioconjugate as a diagnostic tool for influenza A virus
por: Ozkan, Busra, et al.
Publicado: (2019) -
Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients
por: Koga, Paula, et al.
Publicado: (2022)